Symbols

OMIC(Delisted)

Singular Genomics·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 1

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About OMIC

Singular Genomics Systems, Inc.

A life science technology company that develops next-generation sequencing and multiomics technologies

Industry

Established Date

Listing Date

05/27/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

255

Fiscal Year Ends

12-31

Website

www.singulargenomics.com

Security Type

Common stock

Office address

3010 Science Park Road, San Diego, California 92121

Business

Introduction

Singular Genomics Systems, Inc., was incorporated in Delaware in June 2016 and its principal operations are in La Jolla, California. Their mission is to accelerate the development of genomics for the advancement of science and medicine. Since the first sequencing of the human genome, genomic tools and technologies developed over the past two decades have greatly improved their understanding of biology, fueling the development of novel therapies and advanced clinical diagnosis. They are a life science technology company that is leveraging novel NGS and multiomics technologies to develop products that empower researchers and clinicians. They developed a unique and proprietary NGS technology called a sequencing engine. The sequencing engine is the underlying platform technology that forms the basis of its product development and its core product tenets: accuracy, speed, flexibility and scale.

Company Financials

EPS

OMIC has released its 2024 Q3 earnings. EPS was reported at -6.72, versus the expected -8.05, beating expectations. The chart below visualizes how OMIC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

OMIC has released its 2024 Q3 earnings report, with revenue of 406.00K, reflecting a YoY change of -12.12%, and net profit of -16.80M, showing a YoY change of 24.89%. The Sankey diagram below clearly presents OMIC's revenue sources and cost distribution.